Skip to main content
. Author manuscript; available in PMC: 2012 Apr 28.
Published in final edited form as: J Med Chem. 2011 Mar 23;54(8):2792–2804. doi: 10.1021/jm101593u

Table 2.

Antiparasitic, antibacterial and cytotoxic activities of selected azalides.

graphic file with name nihms283584u1.jpg
IC50 (μM)
MICa (μM) CC50b (μM)
0h
6h
1st cycle 2nd cycle 1st cycle 2nd cycle
3 29 ± 2 0.6 ± 0.07 44 ± 5 0.6 ± 0.03 0.15 174

11 5 ± 1 0.5 ± 0.10 9 ± 1 0.5 ± 0.05 0.3 32

18 7 ± 0.3 5 ± 0.2 10 ± 1 4 ± 0.5 0.3 13

25 7 ± 1 10 ± 1 > 10 > 10 6.0 14

28 5 ± 1 0.6 ± 0.04 9 ± 1 0.7 ± 0.05 0.3 38

29 6 ± 1 0.5 ± 0.07 9 ± 1 0.7 ± 0.01 0.3 31

30 4 ± 1 0.6 ± 0.06 8 ± 1 0.6 ± 0.01 0.6 33

31 7 ± 1 0.6 ± 0.10 12 ± 2 0.6 ± 0.07 0.3 36

“0 h” data refers to results from experiments in which macrolide and parasite were simultaneously added to fibroblast cultures, whereas “6 h” data was obtained from experiments in which parasites were first allowed to infect before addition of the macrolide.

a

MIC: minimum inhibitory concentration against B. subtilis.

b

CC50: cytotoxic concentration at which human foreskin fibroblast viability drops by 50%